Daniel J. DeSalvo

4.8k total citations · 1 hit paper
84 papers, 2.0k citations indexed

About

Daniel J. DeSalvo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Daniel J. DeSalvo has authored 84 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Endocrinology, Diabetes and Metabolism, 41 papers in Surgery and 38 papers in Genetics. Recurrent topics in Daniel J. DeSalvo's work include Diabetes Management and Research (70 papers), Diabetes and associated disorders (38 papers) and Pancreatic function and diabetes (38 papers). Daniel J. DeSalvo is often cited by papers focused on Diabetes Management and Research (70 papers), Diabetes and associated disorders (38 papers) and Pancreatic function and diabetes (38 papers). Daniel J. DeSalvo collaborates with scholars based in United States, Austria and Australia. Daniel J. DeSalvo's co-authors include Kellee M. Miller, Lori M. Laffel, Mark A. Clements, Bruce A. Buckingham, Jennifer L. Sherr, Linda A. DiMeglio, Marisa E. Hilliard, David M. Maahs, Barbara J. Anderson and William V. Tamborlane and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Daniel J. DeSalvo

74 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes

2020 268 citations Lori M. Laffel, Lauren Kanapka et al. profile →

Peers

Daniel J. DeSalvo

EDM

GENET

SURGE

GHP

Kellee M. Miller United States

Cari Berget United States

Stephanie N. DuBose United States

Torben Biester Germany

Sarah J. Hanes United States

Eric A. Orzeck United States

Katrina Ramsey United States

Dag Helge Frøisland Norway

Shivani Agarwal United States

Fernando Coto‐Yglesias United States

Kellee M. Miller United States

Daniel J. DeSalvo

2.4k ×1.4

EDM

1.4k ×1.4

GENET

1.3k ×1.4

SURGE

272 ×1.3

GHP

276 ×2.2

Citations per year, relative to Daniel J. DeSalvo Daniel J. DeSalvo (= 1×) peers Kellee M. Miller

Countries citing papers authored by Daniel J. DeSalvo

Since Specialization

Citations

This map shows the geographic impact of Daniel J. DeSalvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. DeSalvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. DeSalvo more than expected).

Fields of papers citing papers by Daniel J. DeSalvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. DeSalvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. DeSalvo. The network helps show where Daniel J. DeSalvo may publish in the future.

Co-authorship network of co-authors of Daniel J. DeSalvo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. DeSalvo. A scholar is included among the top collaborators of Daniel J. DeSalvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. DeSalvo. Daniel J. DeSalvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erraguntla, Madhav, et al.. (2025). Real‐World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes. Pediatric Diabetes. 2025(1). 5053872–5053872.

Hilliard, Marisa E., Wendy Levy, Ruth S. Weinstock, et al.. (2025). Design of the type 1 diabetes and life (T1DAL) pilot and feasibility study: A brief telehealth intervention targeting health-related quality of life across clinical settings. Contemporary Clinical Trials Communications. 45. 101491–101491. 1 indexed citations

Jaser, Sarah S., Marisa E. Hilliard, Joyce P. Yi‐Frazier, et al.. (2025). SCI – U: Validation of an updated Self-Care Inventory for contemporary diabetes management in adolescents with type 1 diabetes. Diabetes Research and Clinical Practice. 224. 112218–112218. 1 indexed citations

Erraguntla, Madhav, et al.. (2025). Hypoglycemia Prediction in Type 1 Diabetes With Electrocardiography Beat Ensembles. Journal of Diabetes Science and Technology. 580928563–580928563.

Carlson, Anders L., et al.. (2024). 265-OR: Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes—A T1D Exchange (T1DX) Online Registry Analysis. Diabetes. 73(Supplement_1). 1 indexed citations

Messer, Laurel H., Kellee M. Miller, Mark A. Clements, et al.. (2023). Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatric Diabetes. 2023. 1–10. 1 indexed citations

Hood, Korey K., William H. Polonsky, Sarah A. MacLeish, et al.. (2023). Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatric Diabetes. 2023. 1–12. 6 indexed citations

Butler, Ashley M., et al.. (2023). Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatric Diabetes. 2023. 1–9. 4 indexed citations

DeSalvo, Daniel J., Stefanie Lanzinger, Nudrat Noor, et al.. (2022). Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. Diabetes Technology & Therapeutics. 24(12). 920–924. 16 indexed citations

10.

Alonso, G. Todd, Sarah Corathers, Carla Demeterco‐Berggren, et al.. (2021). Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative. Clinical Diabetes. 39(3). 256–263. 21 indexed citations

11.

Lee, Joyce M., Emily Carlson, Anastasia Albanese-O’Neill, et al.. (2021). Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic. Diabetes Technology & Therapeutics. 23(9). 642–651. 56 indexed citations

12.

DeSalvo, Daniel J., Nudrat Noor, Sarah Corathers, et al.. (2021). Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. Journal of Diabetes Science and Technology. 17(2). 322–328. 80 indexed citations

13.

Sherr, Jennifer L., Bruce W. Bode, Gregory P. Forlenza, et al.. (2021). 70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D). Diabetes. 70(Supplement_1). 1 indexed citations

14.

DiMeglio, Linda A., Lauren Kanapka, Daniel J. DeSalvo, et al.. (2020). Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabetic Medicine. 37(8). 1308–1315. 16 indexed citations

15.

Casu, Anna, Lauren Kanapka, Nicole C. Foster, et al.. (2020). Characteristics of adult‐ compared to childhood‐onset type 1 diabetes. Diabetic Medicine. 37(12). 2109–2115. 13 indexed citations

16.

Alonso, G. Todd, Sarah Corathers, Avni Shah, et al.. (2020). Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Clinical Diabetes. 38(2). 141–151. 55 indexed citations

17.

Corathers, Sarah & Daniel J. DeSalvo. (2020). Therapeutic Inertia in Pediatric Diabetes: Challenges to and Strategies for Overcoming Acceptance of the Status Quo. Diabetes Spectrum. 33(1). 22–30. 8 indexed citations

18.

Commissariat, Persis, Kara R. Harrington, Kellee M. Miller, et al.. (2019). “I'm essentially his pancreas”: Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes. Pediatric Diabetes. 21(2). 377–383. 66 indexed citations

19.

Hilliard, Marisa E., Wendy Levy, Barbara J. Anderson, et al.. (2019). Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(9). 493–498. 94 indexed citations

20.

Name, Michelle Van, Marisa E. Hilliard, Claire T. Boyle, et al.. (2018). Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. PMC. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact